Company: FVN
Filing Date: 2025-04-14
Form Type: DRS/A
Source: 0001829126-25-002616
Chunk: 141

Company: Future Vision II Acquisition Corp.
Filing Date: 2025-04-14
Form: DRS/A
Chunk 141
---
 VIWO will be required to file an annual report on Form 20-F within four months of the end of each fiscal year. In addition, New VIWO intends to publish its results on a quarterly basis through press releases, distributed pursuant to the rules and regulations of Nasdaq. Press releases relating to financial results and material events will also be furnished to the SEC on Form 6-K. However, the information New VIWO is required to file with or furnish to the SEC will be less extensive and less timely compared to that required to be filed with the SEC by U.S. domestic issuers. Accordingly, after the Business Combination, if you continue to hold New VIWO’s securities, you may receive less or different information about New VIWO than you currently receive about Future Vision or that you would receive about a U.S. domestic public company.

New VIWO could lose its status as a foreign private issuer under current SEC rules and regulations if more than 50% of New VIWO’s outstanding voting securities become directly or indirectly held of record by U.S. holders and any one of the following is true: (i) the majority of New VIWO’s directors or executive officers are U.S. citizens or residents; (ii) more than 50% of New VIWO’s assets are located in the United States; or (iii) New VIWO’s business is administered principally in the United States. If New VIWO loses its status as a foreign private issuer in the future, it will no longer be exempt from the rules described above and, among other things, will be required to file periodic reports and annual and quarterly financial statements as if it were a company incorporated in the United States. If this were to happen, New VIWO would likely incur substantial costs in fulfilling these additional regulatory requirements and members of New VIWO’s management would likely have to divert time and resources from other responsibilities to ensuring these additional regulatory requirements are fulfilled.

As an exempted company incorporated in the Cayman Islands, New VIWO will be permitted to adopt certain home country practices in relation to corporate governance matters that differ significantly from the Nasdaq listing standards; these practices may afford less protection to shareholders than they would enjoy if New VIWO complied fully with the Nasdaq listing standards.

As a Cayman Islands exempted company intending to apply to list its securities on Nasdaq, New VIWO will be subject to the Nasdaq corporate governance listing standards. However, the Nasdaq rules will permit a foreign private issuer like New VIWO to follow the corporate governance practices of New